Results 21 to 30 of about 48,159 (229)

The first investigation on differences in the effectiveness of mycophenolate mofetil and azathioprine antimetabolites determined in Polish patients treated for non-infectious uveitis

Annals of Agricultural and Environmental Medicine, 2020
Introduction The non-infectious uveitis, a serious vision-threatening disease is the fourth most common cause of blindness in working population of the developed world.
Maja Waszczyk-Łączak, Monika Łazicka-Gałecka, Lidia Chomicz, Krzysztof Mucha, Leszek Pączek, Jacek P. Szaflik   +5 more
doaj   +1 more source

Mycophenolate Mofetil-Induced Pneumatosis Intestinalis [PDF]

Gastro Hep Advances
Daphne Moutsoglou, Byron P. Vaughn
doaj   +2 more sources

Topical mycophenolate mofetil in the treatment of vitiligo: a pilot study

Dermatology Practical & Conceptual, 2017
Background: Vitiligo is a multifactorial disease that is characterized by circumscribed depigmented macules and patches. Autoimmune reactions may play an important role in the pathogenesis of the disease. Mycophenolate mofetil is a drug that inhibits DNA
Farhad Handjani, Shahin Aghaei, Iman Moezzi, Nasrin Saki   +3 more
doaj   +1 more source

Mycophenolate mofetil and atherosclerosis

Научно-практическая ревматология, 2009
Акселерация атеросклероза, приводящего к коронарной болезни и другим кардиальным нарушениям, повышает значимость адекватно подобранной терапии в улучшении исходов системной красной волчанки (СКВ).
Z S Alekberova, T V Popkova, E L Nasonov
doaj   +1 more source

Optimization of Xanthan Gum and Sorbitol Levels in the Mycophenolate Mofetil Powder for Oral Suspension [PDF]

مجله دانشگاه علوم پزشکی گیلان, 2023
Background Mycophenolate mofetil as an immunosuppressive agent is widely administered in patients with kidney disorders and following organ transplantation.
Amin Umrani, Homa Faghihi, Zohreh Mohammadi, Parastoo Mirzabeigi, Hamed Montazeri Ghods, Ali Rastegari   +5 more
doaj  

Severe Relapsing Goodpasture's Disease Successfully Treated with Mycophenolate Mofetil

International Journal of Nephrology, 2010
Goodpasture's disease is a rare autoimmune disorder characterised by the development of antiglomerular basement membrane autoantibodies, which typically presents with rapidly progressive crescentic glomerulonephritis and pulmonary haemorrhage. Even with
Anabela Malho, Viriato Santos, Ana Cabrita, Ana Paula Silva, Isabel Pinto, Idalécio Bernardo, Pedro Leão Neves   +6 more
doaj   +1 more source

LESIONS OF THE HEMATOPOIETIC SYSTEM IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND THE EFFECTIVENESS OF TREATMENT WITH MYCOPHENOLATE MOFETIL

Проблеми екології та медицини, 2022
The article presents a clinical case of the use of mycophenolate mofetil in a patient with high activity of systemic lupus erythematosus (SLE) and suppression of hematopoietic systems.
I.A. Mormol, O.A. Borzykh, N.D. Gerasymenko, C. Esanu, L.P. Ozarchuk   +4 more
doaj   +1 more source

Acute Liver Rejection in a Multiple Myeloma Patient Treated with Lenalidomide

Case Reports in Transplantation, 2020
Herein we present a patient that underwent a liver transplant due to primary biliary cholangitis (PBC) and after 9 years developed multiple myeloma. Following the cessation of mycophenolate mofetil and 2 weeks after lenalidomide treatment was started ...
Iuliana Vaxman, John Eaton, Hee Eun Lee, Morie A. Gertz   +3 more
doaj   +1 more source

Mycophenolate mofetil in giant cell arteritis

Frontiers in Medicine, 2023
IntroductionGiant cell arteritis (GCA) is a systemic granulomatous vasculitis affecting the large arteries. Abnormal lymphocyte function has been noted as a pathogenic factor in GCA.
Anne Pankow, Anne Pankow, Sena Sinno, Thorsten Derlin, Marcus Hiss, Annette D. Wagner   +5 more
doaj   +1 more source

"TREATMENT OF CHRONIC PLAQUE TYPE PSORIASIS WITH SYSTEMIC MYCOPHENOLATE MOFETIL " [PDF]

Acta Medica Iranica, 2006
Chronic plaque-type psoriasis may be difficult to control without the use of potent systemic therapies that are accompanied by systemic toxicity. Mycophenolate mofetil is a novel agent that may be effective in the treatment of chronic plaque type ...
M. Akhyani, S. Toosi R. M. Robati   +1 more
doaj   +1 more source